IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Clinical trial NCT01265901 · COMPLETED

Trial details

NCT number: NCT01265901
Sponsor: Immatics Biotechnologies GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2010-12-01
Primary completion: 2015-07-01
Enrollment: 339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.